These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29736731)
1. Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma mansoni. de Oliveira SA; de Oliveira Barbosa M; Filho CALM; Oliveira AR; de Sousa FA; de Farias Santiago E; de Oliveira Filho GB; de Moraes Gomes PAT; da Conceição JM; Brayner FA; Alves LC; Leite ACL Parasitol Res; 2018 Jul; 117(7):2105-2115. PubMed ID: 29736731 [TBL] [Abstract][Full Text] [Related]
2. Schistosomicidal and prophylactic activities of phthalimido-thiazoles derivatives on schistosomula and adult worms. de Oliveira Barbosa M; de Oliveira SA; Filho CALM; Oliveira AR; Fernandes CJB; Lucena JP; de Sousa FA; de Barros Dias MCH; Brayner FA; Alves LC; Leite ACL Eur J Pharm Sci; 2019 May; 133():15-27. PubMed ID: 30877068 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of multi-target phtalimido-thiazoles on Schistosomiasis mansoni. Filho CALM; Barbosa MO; Oliveira AR; Santiago EF; de Souza VCA; Lucena JP; Fernandes CJB; Santos IRD; Leão RLC; Santos FABD; Alves LC; Pereira VRA; de Araújo RE; Leite ACL; de Oliveira SA Eur J Pharm Sci; 2020 Apr; 146():105236. PubMed ID: 32058057 [TBL] [Abstract][Full Text] [Related]
4. The prophylactic and anti-fibrotic activity of phthalimido-thiazole derivatives in schistosomiasis mansoni. Laranjeira Miranda Filho CA; de Oliveira Barbosa M; Rodrigues Oliveira A; Ferreira Pinto A; Araújo DL; Lucena JP; de Araújo RE; de Oliveira SA; Lima Leite AC Parasitol Res; 2022 Jul; 121(7):2111-2120. PubMed ID: 35599272 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles. Santiago Ede F; de Oliveira SA; de Oliveira Filho GB; Moreira DR; Gomes PA; da Silva AL; de Barros AF; da Silva AC; Dos Santos TA; Pereira VR; Gonçalves GG; Brayner FA; Alves LC; Wanderley AG; Leite AC Antimicrob Agents Chemother; 2014; 58(1):352-63. PubMed ID: 24165185 [TBL] [Abstract][Full Text] [Related]
6. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni. de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of aryl-thiazole derivatives against Schistosoma mansoni schistosomula and adult worms. Pereira ASA; Silveira GO; Amaral MS; Almeida SMV; Oliveira JF; Lima MCA; Verjovski-Almeida S PLoS One; 2019; 14(11):e0225425. PubMed ID: 31765429 [TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of cytotoxicity and leishmanicidal activity of phthalimido-thiazole derivatives. Aliança ASDS; Oliveira AR; Feitosa APS; Ribeiro KRC; de Castro MCAB; Leite ACL; Alves LC; Brayner FA Eur J Pharm Sci; 2017 Jul; 105():1-10. PubMed ID: 28478133 [TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. de Oliveira RN; Rehder VL; Santos Oliveira AS; Júnior ÍM; de Carvalho JE; de Ruiz AL; Jeraldo Vde L; Linhares AX; Allegretti SM Exp Parasitol; 2012 Oct; 132(2):135-43. PubMed ID: 22771865 [TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel. Shaw MK Parasitology; 1990 Feb; 100 Pt 1():65-72. PubMed ID: 2107508 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity, ultrastructural analysis and in silico pharmacokinetic properties (ADMET) of thiazole compounds against adult worms of Schistosoma mansoni. Silva DVSPD; Nascimento PHDB; Rocha JVRD; Marques DSC; Brayner FA; Alves LC; Araújo HDA; Cruz Filho IJD; Albuquerque MCPA; Lima MDCA; Aires AL Acta Trop; 2023 Sep; 245():106965. PubMed ID: 37295486 [TBL] [Abstract][Full Text] [Related]
12. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638 [TBL] [Abstract][Full Text] [Related]
13. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis. Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735 [TBL] [Abstract][Full Text] [Related]
14. Miltefosine, a promising novel agent for schistosomiasis mansoni. Eissa MM; El-Azzouni MZ; Amer EI; Baddour NM Int J Parasitol; 2011 Feb; 41(2):235-42. PubMed ID: 21055404 [TBL] [Abstract][Full Text] [Related]
15. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems. Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281 [TBL] [Abstract][Full Text] [Related]
16. Antischistosomal activity of aminoalkanethiols, aminoalkanethiosulfuric acids and the corresponding disulfides. de Oliveira Penido ML; Zech Coelho PM; de Mello RT; Piló-Veloso D; de Oliveira MC; Kusel JR; Nelson DL Acta Trop; 2008; 108(2-3):249-55. PubMed ID: 18996349 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni. Mossallam SF; Amer EI; El-Faham MH Acta Trop; 2015 Mar; 143():36-46. PubMed ID: 25530543 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of usnic acid potassium salt against different developmental stages of Schistosoma mansoni: An ultrastructural study. Araújo HDA; Santos VHB; Brayner FA; Alves LC; Silva NH; Albuquerque MCPA; Aires AL; Lima VLM Acta Trop; 2020 Jan; 201():105159. PubMed ID: 31491401 [TBL] [Abstract][Full Text] [Related]
19. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays. Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714 [TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine. da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]